Biocon may acquire Siro Clinpharm - MarketLine Financial Deals

Biocon may acquire Siro Clinpharm

Biocon may acquire Siro Clinpharm - MarketLine Financial Deals
Biocon may acquire Siro Clinpharm
Published Jan 25, 2010
2 pages — Published Jan 25, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

According to Businessworld, Biocon, Ltd., a healthcare company that delivers biopharmaceutical solutions, is in talks to acquire SIRO Clinpharm Private Limited, a full-service clinical research organization. The transaction is valued at approximately INR4,000 million ($86.56 million).

  
Source:
Document ID
MA18146_100201
Country
Ticker
532523=IN
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Biocon may acquire Siro Clinpharm" Jan 25, 2010. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Biocon-may-acquire-Siro-Clinpharm-2052-22836>
  
APA:
MarketLine Financial Deals. (2010). Biocon may acquire Siro Clinpharm Jan 25, 2010. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Biocon-may-acquire-Siro-Clinpharm-2052-22836>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.